Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-011-1072-2PMID 21959972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of Resistance towards Artesunate in MDA-MB-231 Human Breast Cancer Cells

  2011cited by this paper
• The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells

  2011cited by this paper
• Abstract 709: Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells

  2011cited by this paper
• Proteomic analysis of cisplatin resistance in human ovarian cancer using 2-DE method

  2011cited by this paper
• Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol

  2011cited by this paper
• Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines.

  2010cited by this paper
• Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer.

  2010cited by this paper
• Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells.

  2010cited by this paper
• Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium‐dependent activation of HIF‐1α and P‐glycoprotein overexpression

  2009cited by this paper
• Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

  2009cited by this paper
• Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo

  2009cited by this paper
• Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target

  2009cited by this paper
• Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy-d-glucose treatment

  2009cited by this paper
• The Roles of HSP27 and Annexin II in Resistance to UVC-Induced Cell Death: Comparative Studies of the Human UVC-Sensitive and -Resistant Cell Lines RSa and APr-1

  2009cited by this paper
• Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy

  2008cited by this paper
• Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.

  2008cited by this paper
• Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line.

  2008cited by this paper
• Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

  2008cited by this paper
• Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species

  2008cited by this paper
• Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.

  2007cited by this paper
• Dihydroartemisinin is an inhibitor of ovarian cancer cell growth

  2007cited by this paper
• Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells

  2007cited by this paper
• Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines.

  2007cited by this paper
• Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds*

  2007cited by this paper
• Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β‐catenin pathway

  2007cited by this paper
• Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.

  2007cited by this paper
• Caspase-8 preferentially senses the apoptosis-inducing action of NG-18, A gambogic acid derivative, in human leukemia HL-60 cells

  2007cited by this paper
• Proteome analysis of multidrug resistance in vincristine‐resistant human gastric cancer cell line SGC7901/VCR

  2006cited by this paper
• Drug discovery in the ubiquitin–proteasome system

  2006cited by this paper
• The history of qing hao in the Chinese materia medica.

  2006cited by this paper
• Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.

  2005cited by this paper
• Two‐dimensional gel electrophoresis maps of the proteome and phosphoproteome of primitively cultured rat mesangial cells

  2005cited by this paper
• The proteasome: a suitable antineoplastic target

  2004cited by this paper
• Molecular modes of action of artesunate in tumor cell lines.

  2003cited by this paper
• Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines.

  2002cited by this paper
• Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.

  2002cited by this paper
• Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene.

  2000cited by this paper

• Anti-proliferation and apoptosis-inducing effects of dihydroartemisinin on SH-SY5Y cells and metabolomic analysis

  2022cites this paper
• A comprehensive overview of Artemisinin and its derivatives as anticancer agents.

  2022cites this paper
• An Overview of Dihydroartemisinin as a Promising Lead Compound for Development of Anticancer Agents.

  2022cites this paper
• The Therapeutic Effects of Dihydroartemisinin on Cisplatin-Resistant Gastric Cancer Cells.

  2021cites this paper
• Cancer Chemoprevention by Flavonoids, Dietary Polyphenols and Terpenoids

  2020cites this paper
• Dihydroartemisinin exposure impairs porcine ovarian granulosa cells by activating PERK-eIF2α-ATF4 through endoplasmic reticulum stress.

  2020cites this paper
• Antitumor Research on Artemisinin and Its Bioactive Derivatives

  2018cites this paper
• From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy.

  2017cites this paper
• Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action

  2017cites this paper
• STUDIES ON THE ANTI-CANCER PROPERTIES OF ARTESUNATE: ANTI-PROLIFERATIVE AND CYTOTOXIC EFFECTS ON BREAST AND OVARIAN CANCER CELLS

  2017cites this paper
• Artemisinin–second career as anticancer drug?

  2015cites this paper
• Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.

  2015cites this paper
• Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.

  2014cites this paper
• Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.

  2014cites this paper
• DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal.

  2014cites this paper
• Potent proapoptotic actions of dihydroartemisinin in gemcitabine-resistant A549 cells.

  2014cites this paper
• Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro.

  2013cites this paper
• Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach

  2013cites this paper
• Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells

  2013cites this paper
• Artemisinic acid: A promising molecule potentially suitable for the semi-synthesis of artemisinin

  2013cites this paper
• Development of artemisinin compounds for cancer treatment

  2013cites this paper
• Anticancer Properties of Distinct Antimalarial Drug Classes

  2013cites this paper
• Qinghaosu (artemisinin): Chemistry and pharmacology

  2012cites this paper
• Terpenoids: natural products for cancer therapy

  2012cites this paper
• Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: an analysis of the mitochondrial proteome.

  2012cites this paper